No Data
No Data
No Data
No Data
No Data
The Recent Pullback Must Have Dismayed Shaanxi Meibang Pharmaceutical Group Co., Ltd. (SHSE:605033) Insiders Who Own 58% of the Company
Key Insights Significant insider control over Shaanxi Meibang Pharmaceutical Group implies vested interests in company growth 53% of the business is held by the top 2 shareholders Using data from
Simply Wall StApr 16 18:32 ET
Shaanxi Meibang Pharmaceutical Group Co., Ltd.'s (SHSE:605033) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
It is hard to get excited after looking at Shaanxi Meibang Pharmaceutical Group's (SHSE:605033) recent performance, when its stock has declined 27% over the past three months. But if you pay close a
Simply Wall StFeb 1 18:37 ET
Meibang Co., Ltd. (605033.SH): 2023 net profit pre-reduced by 55%-64%
Gelonghui, January 29丨Meibang Co., Ltd. (605033.SH) announced the pre-reduction announcement for the 2023 annual results. According to preliminary estimates by the financial department, the company expects to achieve net profit attributable to shareholders of listed companies in 2023 of about 52-65 million yuan. Compared with the same period last year (statutory disclosure data), it will decrease by 80,000-93.09 million yuan, a year-on-year decrease of 55%-64%. In 2023, net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss is expected to be approximately RMB 3604-49.04 million. Compared with the same period last year (statutory disclosure data),
Gelonghui FinanceJan 29 04:55 ET
Meibang Co., Ltd. (605033.SH): Received a government subsidy of 14.134,900 yuan
Gelonghui, January 2, 丨 Meibang Co., Ltd. (605033.SH) announced that from January 1, 2023 to December 29, 2023, the company and its subsidiaries and branches received a total of 14.134,900 yuan in government subsidies related to revenue, accounting for 9.7424% of the company's 2022 audited net profit attributable to shareholders of listed companies.
Gelonghui FinanceJan 2 04:53 ET
[Instant Analysis of BT Financial Report] Meibang Co., Ltd. 2023 Third Quarter Report: Balance Ratio Decreased, Net Cash Flow Increased Significantly
Announcement time of this financial report: 2023-10-25 17:21:17 Meibang Co., Ltd. (stock code: 605033) is an enterprise focusing on R&D, production, sales and agricultural technology promotion and service of pesticide formulations. Its main products include pesticides, fungicides, plant growth regulators, etc. The company has 25 years of deep experience in the Chinese rural market and has long been committed to promoting agricultural technology and providing services to farmers. As the top 100 sales enterprises in the national pesticide industry and the top 20 domestic pesticide formulation manufacturers, the company has good market competitiveness. According to the 2023 three-quarter report of Meibang Co., Ltd.
businesstimes cnOct 26, 2023 04:13 ET
Meibang Co., Ltd. (605033.SH) released third-quarter results, with a net loss of 3,419,900 yuan
Meibang Co., Ltd. (605033.SH) released its report for the third quarter of 2023, with the company's operating income of 7748.6...
Zhitong FinanceOct 25, 2023 06:04 ET
No Data
No Data